HOME >> BIOLOGY >> NEWS
Parkinson's protein protects neurons from stress induced cell death

The scientists could show that Parkin prevents the induction of neuronal cell death. As reported in the "Journal of Neuroscience", the protein activates a survival mechanism which had been known for its prominent role in immune response.

Usually, Parkinsons disease occurs after the age of 50 and in Germany about 400,000 people are affected. It is characterized by a decline of neurons in the so-called Substantia Nigra, a structure in the midbrain that produces dopamine. The resulting deprivation of this messenger substance causes symptoms like muscular tremor at rest and restricted mobility and even complete immobility. Characteristic deposits are found in the brain, the Lewy corpuscles.

Little is known about the causes of Parkinsons disease. It has only been known for a few years that ten to fifteen per cent of all cases are associated with mutations in certain genes.

"The parkin gene is of special interest here", says Winklhofer. "One effect of its inactivation is that the Parkin protein loses its physiological function. This genetic defect plays a role for hereditary Parkinsons disease, which may lead to an early onset of the disease."

However, inactivation of the Parkin protein could also contribute to sporadic forms of the disease. In these cases massive oxidative stress probably results in misfolding and aggregation of the protein. "Interestingly, misfolding of Parkin proteins has recently been observed in the brain of patients with sporadic Parkinsons disease", Winklhofer reports.

The scientists could now show in their study that Parkin protects the neuronal cells by mediating the activation of the nuclear protein NF-B ("Nuclear Factor-kappaB"). This protein is known for triggering a survival programme in many human cells, which prevents cell death under stress conditions. The experiments indicate that mutations in the parkin gene result in an impaired activation of NF-B.

"This, however, promo
'"/>

Contact: Heinz-Joerg Haury
oea@gsf.de
49-893-187-2460
GSF - National Research Center for Environment and Health
21-May-2007


Page: 1 2

Related biology news :

1. Scientists identify 2 distinct Parkinsons networks
2. Tracing Parkinsons lethal mechanism
3. Lancet study shows gene therapy for Parkinsons disease is safe and some patients benefit
4. Gene therapy study shows safety and statistically significant improvement in Parkinsons disease
5. PINK1 protects from Parkinsons
6. UCLA researchers discover link between Parkinsons and narcolepsy
7. Alzheimers, Parkinsons, type 2 diabetes similar at molecular level
8. Nanotechnology offers hope for treating spinal cord injuries, diabetes and Parkinsons disease
9. New studies link the environment to Parkinsons disease
10. NIH announces phase III clinical trial of creatine for Parkinsons disease
11. The Parkinsons Institute to conduct Phase III Clinical Trial of creatine for Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2020)... ... February 14, 2020 , ... ... that include integrated eTMF and Payment tracking, will be showcasing SimpleTrials at the ... , Since attending the SCOPE Summit last year, the SimpleTrials team has completed ...
(Date:2/11/2020)... ... February 11, 2020 , ... Modality Solutions, ... its ISO 9001:2015 registration by certification body Intertek. Modality Solutions’ Quality Manager, Hannah ... revised all existing Standard Operating Procedures (SOPs) and created ten new SOPs. Anderson ...
(Date:2/6/2020)... ... February 06, 2020 , ... Syntactx, ... device and pharmaceutical trials, announced that Ms. Dorothy Abel has joined the ... oversees the development and execution of regulatory plans designed to help clients ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... , ... Ideal Implant CEO and President Robert S Hamas, ... American investor forums specializing in medical advancements. New technology was presented to US ... November 21, 2019 in New York City, and the Aesthetic Technology Summit in ...
(Date:1/22/2020)... ... January 21, 2020 , ... QCDx , a private biotech company ... blood draw, today announced the sale of the proprietary RareScope™ instrument to the Carole ... used in clinical cancer research. , “The RareScope can detect and isolate intact and ...
(Date:1/8/2020)... ... 08, 2020 , ... Anomet Products has introduced ... use in harsh environments inside or outside of the human body. , ... alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures ...
(Date:1/7/2020)... and SOMERVILLE, Mass. (PRWEB) , ... January 06, ... ... Murrow Center for a Digital World at The Fletcher School at Tufts University, ... Alfred P. Sloan Foundation. The grant will be administered by Tufts University, and ...
Breaking Biology Technology:
Cached News: